Cibinqo and Disease recurrence - a phase IV clinical study of FDA data

Summary:

Disease recurrence is reported as a side effect among people who take Cibinqo (abrocitinib), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Triamcinolone, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Disease recurrence when taking Cibinqo. It is created by eHealthMe based on reports of 1,829 people who have side effects when taking Cibinqo from the FDA, and is updated regularly.

What is Cibinqo?

Cibinqo has active ingredients of abrocitinib. eHealthMe is studying from 1,830 Cibinqo users. Check the latest studies of Cibinqo.

What is Disease recurrence?

Disease recurrence is found to be associated with 1,242 drugs and 1,552 conditions by eHealthMe. Check the latest studies of Disease recurrence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,829 people reported to have side effects when taking Cibinqo.
Among them, 11 people (0.6%) have Disease recurrence.

Among these 11 people:

How long have people been on Cibinqo when they have Disease recurrence? *

What is the gender of people who have Disease recurrence when taking Cibinqo? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Disease recurrence when taking Cibinqo? *

What are other drugs people take besides Cibinqo? *

Triamcinolone: 2 people, 18.18%
Xyzal: 1 person, 9.09%
Qvar: 1 person, 9.09%
Olopatadine Hydrochloride: 1 person, 9.09%
Lamisil: 1 person, 9.09%
Hydroxyzine: 1 person, 9.09%
Duloxetine Hydrochloride: 1 person, 9.09%
Dayvigo: 1 person, 9.09%
Betamethasone Dipropionate: 1 person, 9.09%

What are other side effects people have besides Disease recurrence? *

Itching: 4 people, 36.36%
Impetigo (contagious skin infection): 2 people, 18.18%
Effusion (an escape of fluid into a body cavity): 2 people, 18.18%
Eczema Herpeticum (feverish condition and widespread eruption of vesicles): 2 people, 18.18%
Swallowing Difficulty: 1 person, 9.09%
Skin Fragility (trauma-induced blisters and erosions of skin): 1 person, 9.09%
Oral Herpes (viral infection of mouth): 1 person, 9.09%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 9.09%
Communication Disorder (speech and language disorder): 1 person, 9.09%
Cellulitis (infection under the skin): 1 person, 9.09%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 36.36%
Itching: 3 people, 27.27%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 27.27%
Rashes (redness): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 9.09%
Dysmenorrhea (painful menstruation): 1 person, 9.09%
Depression: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cibinqo and have Disease recurrence?

- Check whether Disease recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cibinqo:

Cibinqo (1,830 reports)

Browse all side effects of Cibinqo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease recurrence:

Disease recurrence (1,242 drugs)

Browse all the conditions that are associated with Disease recurrence:

Disease recurrence (1,552 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abrocitinib (the active ingredients of Cibinqo) and Cibinqo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.